ECS Botanics to relaunch Terphogz range after quasi-rec ‘misfire’ by Steve Jones March 9, 2026March 10, 2026 ECS Botanics will relaunch Terphogz products into the Australian and international markets over the next six […]
Closed-loop models on regulator radar after being branded the ‘main driver of industry concerns’ by Steve Jones March 5, 2026March 5, 2026
ECS Botanics delivers cash flow positive December quarter by Adam Sheldon January 14, 2026January 14, 2026
News in brief: ECS explores US move; Epsilon reports half-year results by Steve Jones December 16, 2025February 21, 2026
ECS Botanics to roll out product range tailored to women’s health by Steve Jones December 4, 2025December 4, 2025
ECS Botanics completes A$1.95m raise to boost product and export plans by Adam Sheldon November 13, 2025February 21, 2026
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025
Industry leaders question ODC data and renew calls for level playing field by Adam Sheldon October 8, 2025October 13, 2025
R&D ‘undercooked’ amid financial pressures but progress being made on industry collaboration, business leaders say by Steve Jones August 18, 2025August 18, 2025
News in brief: Althea completes medical cannabis asset sales; Argent begins clinical supply in Slovenia; ECS backs UWA trial for sleep apnoea by Adam Sheldon July 8, 2025July 9, 2025
